In 2023, there were **** deaths from diabetes mellitus per 100,000 people in the United States. The death rate caused by this condition has fluctuated over the past decades, reaching almost ** deaths per 100,000 people in the early 2000s, and about ** deaths in 1980. Prevalence of diabetes In 2022, around *** percent of the adult population in the U.S. had diabetes. In total, around ** million adults in the United States are currently living with diabetes. Of this total, the vast majority were aged 45 years and older. The states with the highest share of adults with diabetes are West Virginia, Mississippi, and Louisiana. Cure for diabetes? Researchers are helping diabetics put their Type 2 diabetes into remission, where the blood sugar levels are kept within a healthy range. For Type 1, scientists are looking for ways to prevent the immune system’s attack on beta cells, which causes diabetes. These cells, located in the pancreas, produce the insulin people need to live. As of yet, there is no cure for diabetes mellitus; however, scientists are researching ways to make diabetes harmless one day.

Diabetes continues to be a significant global health concern, with the Western Pacific region reporting the highest number of diabetes-related deaths in 2024, with around 1.2 million. This stark figure underscores the urgent need for improved diabetes prevention and management strategies worldwide. North America and the Caribbean followed with an estimated 526,000 deaths, while Africa is had the lowest number at 216,000. Regional disparities and global impact The prevalence of diabetes varies significantly across regions, reflecting differences in healthcare systems, lifestyle factors, and genetic predispositions. In the United States, the death rate from diabetes mellitus was 22.4 per 100,000 people in 2023, with 8.4 percent of the adult population living with the condition. Canada has seen a slight decrease in its diabetes-related death rate, falling from 21.8 per 100,000 in 2000 to 18.1 per 100,000 in 2023. These figures highlight the ongoing challenges in managing diabetes, even in countries with advanced healthcare systems. European landscape and global context Within Europe, Germany reported the highest number of diabetes-related deaths in 2024, with nearly 63,000 fatalities among adults aged 20 to 79 years. Italy followed closely with around 62,400 deaths. However, Czechia reported the highest mortality rates in Europe as of 2022, with 43.4 diabetes deaths per 100,000 population overall. On a global scale, diabetes remains a major health concern, with 19 percent of adults worldwide identifying it as one of the biggest health problems in their country.

In 2024, Germany recorded almost ****** deaths related to diabetes among adults aged 20 to 79 years, the highest number of diabetes-related deaths in Europe. Italy had the second-highest number of deaths related to diabetes that year, with around ******. Mortality rates and hospital admissions While Germany had the highest absolute number of diabetes-related deaths, Czechia reported the highest mortality rates in Europe as of 2022. The country recorded **** diabetes deaths per 100,000 population overall, with rates of **** and **** per 100,000 for males and females, respectively. In terms of hospital admissions, Turkey and Germany saw significant numbers, with approximately *** and *** admissions per 100,000 population, respectively, in 2021. Complications and global context Diabetes-related complications pose serious risks, as evidenced by the high rates of major lower extremity amputations in countries like Romania and Czechia, which in 2021 reported **** and **** amputations among diabetes sufferers per 100,000 population, respectively. On a global scale, diabetes remains a major health concern, with ** percent of adults worldwide identifying it as one of the biggest health problems in their country as of 2024. The impact of diabetes extends beyond Europe, with the region of Western Pacific experiencing an estimated ***** thousand diabetes-related deaths among those aged 60 years and younger in the year 2021.

To reduce deaths from diabetes.

Rate: Age-adjusted death rate, number of deaths due to diabetes, per 100,000 population.

Definition: Deaths with diabetes as the underlying cause of death (ICD-10 codes: E10-E14).

Data Sources:

(1) Death Certificate Database, Office of Vital Statistics and Registry, New Jersey Department of Health

(2) Population Estimates, State Data Center, New Jersey Department of Labor and Workforce Development

The graph displays the number of diabetes-related deaths in the United States from 1999 to 2023. The x-axis represents the years, shown as full four-digit numbers from 1999 to 2023, while the y-axis shows the total number of annual deaths attributed to diabetes. Over this period, the number of deaths ranged from a low of 68,399 in 1999 to a peak of 103,000 in 2021. A sharp rise in diabetes deaths occurred between 2019 and 2021, followed by a gradual decline in the subsequent years. The graph highlights year-to-year changes in diabetes mortality rates.

It was estimated that as of 2023, around **** million people in the United States had been diagnosed with diabetes. The number of people diagnosed with diabetes in the U.S. has increased in recent years and the disease is now a major health issue. Diabetes is now the seventh leading cause of death in the United States, accounting for ******percent of all deaths. What is prediabetes? A person is considered to have prediabetes if their blood sugar levels are higher than normal but not high enough to be diagnosed with type 2 diabetes. As of 2021, it was estimated that around ** million men and ** million women in the United States had prediabetes. However, according to the CDC, around ** percent of these people do not know they have this condition. Not only does prediabetes increase the risk of developing type 2 diabetes, but also increases the risk of heart disease and stroke. The states with the highest share of adults who had ever been told they have prediabetes are California, Hawaii, and New Mexico. The prevalence of diabetes in the United States As of 2023, around *** percent of adults in the United States had been diagnosed with diabetes, an increase from ****percent in the year 2000. Diabetes is much more common among older adults, with around ** percent of those aged 60 years and older diagnosed with diabetes, compared to just ****percent of those aged 20 to 39 years. The states with the highest prevalence of diabetes among adults are West Virginia, Mississippi, and Louisiana, while Utah and Colorado report the lowest rates. In West Virginia, around ** percent of adults have been diagnosed with diabetes.

United States US: Diabetes Prevalence: % of Population Aged 20-79 data was reported at 10.790 % in 2017. United States US: Diabetes Prevalence: % of Population Aged 20-79 data is updated yearly, averaging 10.790 % from Dec 2017 (Median) to 2017, with 1 observations. United States US: Diabetes Prevalence: % of Population Aged 20-79 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Diabetes prevalence refers to the percentage of people ages 20-79 who have type 1 or type 2 diabetes.; ; International Diabetes Federation, Diabetes Atlas.; Weighted average;

Age-adjusted rate of diabetes deaths by sex, race/ethnicity, age; trends if available. Source: Santa Clara County Public Health Department, VRBIS, 2007-2016. Data as of 05/26/2017; U.S. Census Bureau; 2010 Census, Tables PCT12, PCT12H, PCT12I, PCT12J, PCT12K, PCT12L, PCT12M; generated by Baath M.; using American FactFinder; Accessed June 20, 2017. METADATA:Notes (String): Lists table title, notes and sources.Year (Numeric): Year of data.Category (String): Lists the category representing the data: Santa Clara County is for total population, sex: Male and Female, race/ethnicity: African American, Asian/Pacific Islander, Latino and White (non-Hispanic White only); age categories as follows: 18 to 24, 25 to 34, 35 to 44, 45 to 54, 55 to 64, 65 to 74, 75 to 84, 85+; United States.Rate per 100,000 people (Numeric): Rate of diabetes deaths. Rates for age groups are reported as age-specific rates per 100,000 people. All other rates are age-adjusted rates per 100,000 people.

Mortality from diabetes (ICD-10 E10-E14 equivalent to ICD-9 250). To reduce deaths from diabetes. Legacy unique identifier: P00303

In 2021, about 6.7 million lives were lost to diabetes across the globe. In China, about 3.9 percent of the total 1.4 million diabetes-related deaths occurred in people aged below 60 years. The world's most populous country had the highest number of diabetics in the world.

The death rate due to diabetes mellitus in Canada has fallen since 2000 from **** per 100,000 population to **** deaths per 100,000 population in 2023. Diabetes is the seventh leading cause of death in Canada. In the United States, it was responsible for **** deaths per 100,000 population in 2023. About diabetesDiabetes mellitus is due to an insufficient production of insulin within the pancreas or a lack of response from the body to the insulin that is produced. The most common type of diabetes mellitus is type II diabetes, which accounts for over ** percent of diabetes cases in the United States. Type II diabetes occurs when cells in the body are unresponsive to insulin and may lead to a decrease in insulin production as well. Prevention and costsOne of the greatest problems with type II diabetes is that it can lead to many different complications such as some types of cancer, cardiovascular disease, and even amputations. This type of diabetes is largely associated with overweight and obese populations and those who are physically inactive. It is also considered a preventable disease by maintaining healthy diets and balanced lifestyles. Health care expenditures to treat diabetes in the United States amounted to around ***** billion U.S. dollars as of 2024, while China, a country with a lower diabetes incidence but a much larger population, spent about *** billion U.S. dollars.

Diabetes age-adjusted mortality rate in Maryland from 2017, by county. These rates are per 100,000 and are age-adjusted to the Year 2000 standard, i.e. to the age distribution of the 2000 population.

Age-adjusted mortality rates are provided by the Office of Chronic Disease Prevention, Maryland Department of Health and Mental Hygiene using mortality data from the Maryland Vital Statistics Administration and population data from Nielsen Claritas.

Data source: Maryland Department of Health and Mental Hygiene, Maryland Vital Statistics Annual Report

Date: 2017

ABSTRACT Objective: to analyze the trend of hospitalization rates and mortality due to Diabetes Mellitus in children and adolescents in Brazil. Method: temporal series study, hospitalization rates and diabetes mortality in children and adolescents. Data were obtained from the Hospital Information System and Mortality Information System, from 2005-2015, with analysis performed by polynomial regression modeling. Results: 87,100 hospitalizations and 1,120 deaths from diabetes were analyzed. Hospitalizations rates increased for both genders and all age groups, with an increase for adolescents aged 10-14 years. The mortality rate declined, except for the 15-19-year age group. In the overall mortality trend in Brazil, the South and Southeast showed a decrease, whereas for hospitalizations only the Center-West remained constant, while the others increased. Conclusion: however, there was a decrease in infant mortality and increase in hospitalizations.

Canada CA: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data was reported at 9.700 % in 2021. This records a decrease from the previous number of 10.000 % for 2020. Canada CA: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data is updated yearly, averaging 11.000 % from Dec 2000 (Median) to 2021, with 22 observations. The data reached an all-time high of 14.400 % in 2000 and a record low of 9.600 % in 2019. Canada CA: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Canada – Table CA.World Bank.WDI: Social: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).;World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).;Weighted average;This is the Sustainable Development Goal indicator 3.4.1 [https://unstats.un.org/sdgs/metadata/].

This dataset contains information on the proportion by age, total number, male and female and sex of adults of adults diagnosed with diabetes, collected from the system of health-related telephone surveys, the Behavioral Risk Factor Surveillance System (BRFSS), conducted in more than 400,000 patients, from 50 states in the US, the District of Columbia and three US territories.

Dominican Republic DO: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data was reported at 21.700 NA in 2016. This stayed constant from the previous number of 21.700 NA for 2015. Dominican Republic DO: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data is updated yearly, averaging 22.000 NA from Dec 2000 (Median) to 2016, with 5 observations. The data reached an all-time high of 24.000 NA in 2000 and a record low of 21.700 NA in 2016. Dominican Republic DO: Mortality from CVD, Cancer, Diabetes or CRD between Exact Ages 30 and 70: Male data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Dominican Republic – Table DO.World Bank.WDI: Health Statistics. Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;

BF: Diabetes Prevalence: % of Population Aged 20-79 data was reported at 2.100 % in 2021. This records a decrease from the previous number of 3.000 % for 2011. BF: Diabetes Prevalence: % of Population Aged 20-79 data is updated yearly, averaging 2.550 % from Dec 2011 (Median) to 2021, with 2 observations. The data reached an all-time high of 3.000 % in 2011 and a record low of 2.100 % in 2021. BF: Diabetes Prevalence: % of Population Aged 20-79 data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Burkina Faso – Table BF.World Bank.WDI: Social: Health Statistics. Diabetes prevalence refers to the percentage of people ages 20-79 who have type 1 or type 2 diabetes. It is calculated by adjusting to a standard population age-structure.;International Diabetes Federation, Diabetes Atlas.;Weighted average;

This statistic displays the number of deaths from diabetes among children and adolescents in the United States from 2000 to 2014, per one million population. According to the statistic, *** children and adolescents died per one million from 2012 to 2014 in the United States.

BackgroundFrailty and diabetes are two important health problems associated with aging in older individuals. This paper seeks to analyze the frailty in older adults suffering from diabetes and the combined effect of diabetes and frailty on mortality risk.MethodsThe frailty index (FI) model was employed when evaluating frailty among the older adults based on the baseline data conducted in 2009; and death as outcome variables collected in 2020 were analyzed. The influence of diabetes on age-related changes in frailty in the older adults and resulting mortality rates was analyzed. Cox regression and Kaplan-Meier curves were applied to evaluate the influence on the risk of death and the 11-year survival of the older adults with varying diabetes and frailty statuses.ResultsUltimately, 1,213 older people aged between 60 and 101, with an average age of (74.79 ± 8.58) at baseline, were included in the analysis. By 2020, there had been 447 deaths with mortality at 36.9% (447/1,213); there were 271 cases of diabetes, with a prevalence of 22.3% (271/1,213). The mean FI value for older adults with diabetes was higher than that of those without regardless of age, and the average annual relative growth rate of the FI value for older adults with diabetes was higher than that of those without diabetes (β = 0.039 vs. β = 0.035, t = 8.367, P < 0.001). For all FI value levels, the mortality rate among older adults with diabetes was higher than that of those without. The Cox Regression analysis showed that, compared with those suffering from neither diabetes nor frailty, older adults with both had the higher mortality risk (HR = 1.760. P < 0.001), followed by older adults suffering from frailty alone (HR = 1.594, P = 0.006), and then by older adults suffering from only diabetes (HR = 1.475, P = 0.033). The survival analysis showed that the median survival of those suffering from diabetes and frailty to be the shortest at just 57.23 (95% CI: 54.05 to 60.41) months, lower than the 83.78 (95% CI: 79.33 to 88.23) months in those suffering from frailty alone, and 119.93 (95% CI: 113.84 to 126.02) months in those with only diabetes, and 124.39 (95% CI: 119.76 to 129.02) months in older adults with neither diabetes nor frailty (P < 0.001).ConclusionFrailty is common among older adults suffering from diabetes, and there is an increased risk of poor health outcomes, such as death, among older adults suffering from diabetes and frailty. When diagnosing, treating, and dealing with older adults with diabetes, attention should be paid to screening and assessing frailty in hopes of identifying it early so that appropriate measures of intervention can be taken to avoid or delay the resulting adverse effects.